Journal article 7 views
Does the short-term use of continuous glucose monitoring enhance diabetes self-management behaviour in type 2 diabetes? The DISCO GM Study: A randomised, controlled cross-over study
,
Steve Luzio ,
Sarah Dowrick,
Gareth Dunseath ,
Ivy Cheung,
Sarah L. Gibbs,
David Owens ,
Jeffrey Stephens
Diabetes & Metabolic Syndrome: Clinical Research & Reviews, Volume: 19, Issue: 7, Start page: 103283
Swansea University Authors:
Sharon Parsons , Steve Luzio , Sarah Dowrick, Gareth Dunseath , Ivy Cheung, David Owens , Jeffrey Stephens
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1016/j.dsx.2025.103283
Abstract
Introduction: There is little evidence on the impact of Continuous Glucose Monitoring (CGM) on self-management behaviour in people with type 2 diabetes using participant reported outcome measures. We aimed to assess whether self-management behaviour, measured by the Diabetes Self-Management Question...
| Published in: | Diabetes & Metabolic Syndrome: Clinical Research & Reviews |
|---|---|
| ISSN: | 1871-4021 1878-0334 |
| Published: |
Elsevier BV
2025
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa70183 |
| Abstract: |
Introduction: There is little evidence on the impact of Continuous Glucose Monitoring (CGM) on self-management behaviour in people with type 2 diabetes using participant reported outcome measures. We aimed to assess whether self-management behaviour, measured by the Diabetes Self-Management Questionnaire (DSMQ), is altered by the short-term use of CGM in people with complex type 2 diabetes. Methods: Open, single-centre, randomised crossover study lasting 36 weeks. Participants were aged >18 years, diagnosed with type 2 diabetes >1 year and HbA1c ≥9%/75mmol/mol. All were receiving care from a specialist diabetes team. Following basic diabetes self-management education and a 10 day period of blinded CGM, participants were randomised to one of two sequences. Sequence 1: 12 weeks routine diabetes care followed by 12 weeks CGM use; Sequence 2: 12 weeks CGM followed by 12 weeks routine diabetes care. Both sequences undertook a 12 week follow up period with no CGM use. Results: Fifty-one participants were randomised, 25 to sequence 1, 26 to sequence 2. At baseline, 62.7% were male, mean age 59.7 years, mean (SD) HbA1c 10.7% (1.07)/93mmol/mol (11.74) and 88.2% were prescribed insulin therapy. DSMQ mean total score pre-CGM was 7.0 (1.37). Following CGM use, DSMQ total and subset scores improved, with total score increasing significantly (mean difference 0.62, 95% CI 0.27, 0.98; p=0.001). Present quality of life, HbA1c and %Time in Range also significantly improved following CGM use. Conclusion: In people with complex type 2 diabetes, the introduction of CGM can significantly improve diabetes self-management behaviour and other important outcomes. |
|---|---|
| Keywords: |
Type 2 diabetes; self-management; Continuous Glucose Monitoring; Patient Reported Outcome Measures |
| College: |
Faculty of Medicine, Health and Life Sciences |
| Funders: |
The study was funded by Dexcom Inc. under the investigator-initiated studies program, with additional support provided by the Diabetes Research Group, Swansea University. |
| Issue: |
7 |
| Start Page: |
103283 |